Eagle’s Eye View: Can Moderate Wine Intake Reduce CV Risk?
In this week’s View, Dr. Eagle looks at increased one-year mortality in younger patients undergoing transcatheter aortic valve replacement (TAVR). He then explores the PREDIMED trial which found that adherence to the Mediterranean diet plus moderate wine intake was associated with reduced cardiovascular risk and mortality. Finally, Dr. Eagle examines 20-year outcomes for pulmonary vein isolation (PVI) in patients with drug-refractory paroxysmal atrial fibrillation (AFib).
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Congenital Heart Disease and Pediatric Cardiology, Diabetes and Cardiometabolic Disease, Invasive Cardiovascular Angiography and Intervention, Prevention, Valvular Heart Disease, Anticoagulation Management and ACS, Anticoagulation Management and Atrial Fibrillation, Implantable Devices, EP Basic Science, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Cardiac Surgery and Arrhythmias, Cardiac Surgery and CHD and Pediatrics, Cardiac Surgery and VHD, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Interventions, CHD and Pediatrics and Prevention, CHD and Pediatrics and Quality Improvement, Interventions and ACS, Interventions and Structural Heart Disease, Diet
Keywords: National Cardiovascular Data Registries, STS/ACC TVT Registry, Transcatheter Aortic Valve Replacement, Bicuspid Aortic Valve Disease, Registries, Diet, Mediterranean, Wine, Risk Factors, Mortality, Acute Coronary Syndrome, Anti-Arrhythmia Agents, Atrial Fibrillation, Pulmonary Veins, Catheter Ablation, Electrophysiology, Anticoagulants, Hemorrhage, Tachycardia
